.png)
Key BenefitsAn active pharmaceutical ingredient is the biologically active component of a medicinal product. The ABDA-Database Active Ingredients Dossiers provide structured monographs that describe active ingredients comprehensively from a clinical-pharmacological perspective.
The dossiers cover synthetic, biotechnological and herbal substances used in allopathy, homeopathy and anthroposophic medicine. Each monograph brings the essential clinical and regulatory attributes of a substance together in one structured record.
The data originates from ABDATA Pharma-Daten-Service in Eschborn, Germany, and is updated twice a month. Access is included in the Drug Dictionaries and Premium subscription packages.
Each dossier consolidates the clinically relevant attributes of an active ingredient into one structured monograph, from indication and contraindication to characteristics and dosages.
Beyond the core drug attributes, the dossiers include pharmacological and toxicological information that supports clinical and regulatory assessment.
The monographs describe synthetic, biotechnological and herbal substances used across allopathy, homeopathy and anthroposophic medicine.
The dossiers are sourced from ABDATA Pharma-Daten-Service in Eschborn and refreshed on a bi-weekly cycle, so records stay aligned with the current data.
Active-ingredient information sits at the centre of pharmaceutical work, from formulation and regulatory affairs to pharmacovigilance and reimbursement. A structured monograph that captures a substance once, consistently, removes the need to reconcile fragmented sources every time a question about a molecule arises.
Free-text references leave clinical and regulatory teams to interpret and reconcile substance data by hand. A dossier that organises indication, contraindication, dosage, side effects, characteristics, stability and dosage into consistent fields lets professionals find and compare the same attributes across substances without re-reading prose.
Every medicinal product traces back to one or more active ingredients. Linking a product to a clear substance monograph, including its pharmacological and toxicological profile, connects the regulatory and commercial view of a drug to its underlying chemistry and clinical behaviour.
Manufacturers, hospital pharmacies, data and API teams and market-access functions all rely on dependable active-ingredient records. The dossiers give each of these groups the same authoritative substance view, maintained by ABDATA and refreshed twice a month.
